Patterns of treatment failure in pediatric and young adult patients with Hodgkin's disease: Local disease control with combined-modality therapy

Journal of Clinical Oncology

Volumn 23, Issue 33, 2005, Pages 8406-8413

  Krasin, Matthew J ^a   Rai, Shesh N ^a   Kun, Larry E ^a   Merchant, Thomas E ^a   Metzger, Monika L ^a   Kaste, Sue C ^a   Howard, Scott C ^a   Hudson, Melissa M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CHILD; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE CONTROL; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RADIATION DOSE; SURVIVAL; TUMOR RECURRENCE; UNITED STATES;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TENNESSEE; TREATMENT FAILURE;

EID: 33644663352     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.00.8763     Document Type: Article

References (24)

1. Shah AB, Hudson MM, Poquette CA, et al: Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital. Int J Radiat Oncol Biol Phys 44:867-877, 1999
2. Ekert H, Toogood I, Downie P, et al: High incidence of treatment failure with vincristine, etoposide, epirubicin, and prednisolone chemotherapy with successful salvage in childhood Hodgkin's disease. Med Pediatr Oncol 32:255-258, 1999
3. Hunger SP, Link MP, Donaldson SS: ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience. J Clin Oncol 12:2160-2166, 1994
4. Weiner MA, Leventhal B, Brecher ML, et al: Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: A Pediatric Oncology Group study. J Clin Oncol 15:2769-2779, 1997
5. Nachman JB, Sposto R, Herzog P, et al: Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 20:3765-3771, 2002
6. Hudson MM, Greenwald C, Thompson E, et al: Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 11:100-108, 1993
7. Ruhl U, Albrecht M, Dieckmann K, et al: Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: An interim report at 5 years of the German GPOH-HD 95 trial. Int J Radiat Oncol Biol Phys 51:1209-1218, 2001
8. Schwartz CL, Constine LS, London W, et al: POG 9425: Response-based, intensively timed therapy for intermediate/high stage (IS/HS) pediatric Hodgkin's disease. Proc Am Soc Clin Oncol 21:389a, 2002 (abstr 1555)
9. Donaldson SS, Hudson MM, Lamborn KR, et al: VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial. J Clin Oncol 20:3081-3087, 2002
10. Donaldson SS, Link MP: Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol 5:742-749, 1987
11. Friedmann AM, Hudson MM, Weinstein HJ, et al: Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. J Clin Oncol 20:3088-3094, 2002
12. Hudson MM, Krasin M, Link MP, et al: Risk-adapted combined modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 22:4541-4550, 2004
13. Smith RS, Chen Q, Hudson MM, et al: Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol 21:2026-2033, 2003
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley, 1980, pp 163-178
16. Cox DR: Regression and life-tables. J Roy Stat Soc B 34:187-220, 1972
17. Dieckmann K, Potter R, Hofmann J, et al: Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Tria DAL-HD-90. Int J Radiat Oncol Biol Phys 56:644-652, 2003
18. Chronowski GM, Wilder RB, Tucker SL, et al: Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy. Int J Radiat Oncol Biol Phys 55:36-43, 2003
19. Mendenhall NP, Rodrigue LL, Moore-Higgs GJ, et al: The optimal dose of radiation in Hodgkin's disease: An analysis of clinical and treatment factors affecting in-field disease control. Int J Radiat Oncol Biol Phys 44:551-561, 1999
20. Horning SJ, Hoppe RT, Breslin S, et al: Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: Mature results of a prospective clinical trial. J Clin Oncol 20:630-637, 2002
21. Bleyer WA: Adolescents and young adults with cancer: A neglected population. American Society of Clinical Oncology Educational Book, pp 125-132, 2001
22. Dorffel W, Luders H, Ruhl U, et al: Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: Analysis and outlook. Klin Padiatr 215:139-145, 2003
23. Krasin MJ, Hudson MM, Kaste SC: Positron emission tomography in pediatric radiation oncology: Integration in the treatment-planning process. Pediatr Radiol 34:214-221, 2004
24. Hudson MM, Krasin MJ, Kaste SC: PET imaging in pediatric Hodgkin's lymphoma. Pediatr Radiol 34:190-198, 2004